Analysis of prognostic factors for patients with chordoma with use of the California Cancer Registry

Journal of Bone and Joint Surgery

Volumn 94, Issue 4, 2012, Pages 356-363

  Lee, Joe ^a   Bhatia, Nitin N ^a,b   Hoang, Bang H ^a,b   Ziogas, Argyrios ^a,b   Zell, Jason A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; CHORDOMA; CRANIAL NERVE TUMOR; ETHNICITY; FEMALE; GROUPS BY AGE; HEAD TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; PELVIS TUMOR; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; SOCIAL STATUS; SPINE TUMOR; TUMOR VOLUME; UNITED STATES;

EID: 84863138255     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.J.01784     Document Type: Article

References (27)

1. Boriani S, Bandiera S, Biagini R, Bacchini P, Boriani L, Cappuccio M, Chevalley F, Gasbarrini A, Picci P, Weinstein JN. Chordoma of the mobile spine: fifty years of experience. Spine (Phila Pa 1976). 2006;31:493-503.
2. Cheng EY, Ozerdemoglu RA, Transfeldt EE, Thompson RC Jr. Lumbosacral chordoma. Prognostic factors and treatment. Spine (Phila Pa 1976). 1999;24:1639-45.
3. Eriksson B, Gunterberg B, Kindblom LG. Chordoma. A clinicopathologic and prognostic study of a Swedish national series. Acta Orthop Scand. 1981;52:49-58. (Pubitemid 11191378)
4. Kelley SP, Ashford RU, Rao AS, Dickson RA. Primary bone tumours of the spine: a 42-year survey from the Leeds Regional Bone Tumour Registry. Eur Spine J. 2007; 16:405-9. (Pubitemid 46440180)
5. McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control. 2001;12:1-11. (Pubitemid 32125896)
6. Stacchiotti S, Casali PG, Lo Vullo S, Mariani L, Palassini E, Mercuri M, Alberghini M, Pilotti S, Zanella L, Gronchi A, Picci P. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol. 2009 Oct 22 [Epub ahead of print].
7. Sundaresan N, Rosen G, Boriani S. Primarymalignant tumors of the spine. Orthop Clin North Am. 2009;40:21-36, v.
8. York JE, Kaczaraj A, Abi-Said D, Fuller GN, Skibber JM, Janjan NA, Gokaslan ZL. Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery. 1999;44:74-80. (Pubitemid 29016169)
9. Ahmed AR. Safety margins in resection of sacral chordoma: analysis of 18 patients. Arch Orthop Trauma Surg. 2009;129:483-7.
10. Chen KW, Yang HL, Lu J, Liu JY, Chen XQ. Prognostic factors of sacral chordoma after surgical therapy: a study of 36 patients. Spinal Cord. 2010;48: 166-71.
11. Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer. 2000;88:2122-34. (Pubitemid 30233215)
12. National Cancer Institute SEER. About the SEER Program. http://seer.cancer. gov/ 2011. Accessed 2009 Aug 23.
13. Seiffert JE, Price WT, Gordon B. The California tumor registry: a state-of-the-art model for a regionalized, automated, population-based registry. Top Health Rec Manage. 1990;11:59-73.
14. Cancer reporting in California: data standards for regional registries and Calfornia Cancer Registry. www.ccrcal.org.
15. California Department of Health Services, Cancer Surveillance Section. Cancer reporting in California: reporting procedures for physicians. California cancer reporting system standards. Vol IV. Sacramento, CA; 2009.
16. Fritz A, Percy C, Jack A, Parkin DM, Shanmugarathan S, Sobin L, Whelan S. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.
17. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001;12:703-11. (Pubitemid 32803497)
18. Le H, Ziogas A, Lipkin SM, Zell JA. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev. 2008;17:1950-62.
19. Parikh-Patel A, Bates JH, Campleman S. Colorectal cancer stage at diagnosis by socioeconomic and urban/rural status in California, 1988-2000. Cancer. 2006; 107(5 Suppl):1189-95. (Pubitemid 44384825)
20. Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL Jr, Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008;26:66-75.
21. Zell JA, Rhee JM, Ziogas A, Lipkin SM, Anton-Culver H. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev. 2007;16:546-52. (Pubitemid 46548659)
22. U.S. Census Bureau, Housing and Household Economic Statistics Division. Poverty definitions. 2008. http://www.census.gov/hhes/www/poverty/methods/ definitions.html. Accessed 2011 Nov 15.
23. Lee J, Hoang BH, Ziogas A, Zell JA. Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer. 2010;116:1964-73.
24. Farsad K, Kattapuram SV, Sacknoff R, Ono J, Nielsen GP. Sacral chordoma. Radiographics. 2009;29:1525-30.
25. Varga PP, Bors I, Lazary A. Sacral tumors and management. Orthop Clin North Am. 2009;40:105-23, vii.
26. Fuller DB, Bloom JG. Radiotherapy for chordoma. Int J Radiat Oncol Biol Phys. 1988;15:331-9.
27. U.S. Census Bureau. General population and housing characteristics: 1990. Geographic area: California. http://factfinder.census.gov/servlet/QTTable?-bm= n&-lang=en&qr-name=DEC-1990-STF1-DP1&ds-name=DEC-1990-STF1- &geo-id=04000US06. 1990. Accessed 2009 Aug 23.